Repetitive short-term bile duct obstruction and relief causes reproducible and reversible bile acid regurgitation. 2003

Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
Department of Surgery, University of Freiburg, Freiburg, Germany. baumgart@chir.ukl.uni-Freiburg.de <baumgart@chir.ukl.uni-Freiburg.de>

BACKGROUND Long-term bile duct obstruction causes sinusoidal regurgitation of bile acids, a shift in bile acid metabolism, and alterations of liver histology. In this study we investigated the regurgitation of bile acids during short-term bile duct obstruction and its reversibility and reproducibility. In addition, the biotransformation of taurodeoxycholate and its appearance in bile and perfusate effluent were studied as well as liver histology. METHODS Rat livers (n = 5) were perfused in vitro with 32 nmol/min/g liver taurodeoxycholate over 85 min with the bile duct being intermittently closed for 30 and 20 min, respectively. RESULTS Within the first 5 min after bile duct obstruction bile acids started to regurgitate to the perfusate effluent amounting to approximately 15% of hepatic uptake until the end of the perfusion period. After relief of obstruction, bile flow and biliary bile acid excretion showed an overshoot phenomenon and were almost doubled compared to preobstruction. In contrast, sinusoidal bile acid regurgitation declined. The same phenomenon was observed during the second closure/opening cycle of the bile duct. Regurgitated bile acids consisted of significantly more taurodeoxycholate metabolites (approximately 70%) than did biliary bile acids (approximately 30%). Histology of liver parenchyma was preserved. CONCLUSIONS During repetitive short-term bile duct obstruction bile acid regurgitation is reversible and reproducible. The absence of altered mechanical barriers suggests that specific pathways are involved in the regurgitation process of bile acids.

UI MeSH Term Description Entries
D008297 Male Males
D002756 Cholagogues and Choleretics Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). Choleretics,Cholagogues,Cholagogues, Choleretics,Choleretics and Cholagogues,Hydrocholeretics
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D005764 Gastroesophageal Reflux Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER. Esophageal Reflux,Gastro-Esophageal Reflux Disease,GERD,Gastric Acid Reflux,Gastric Acid Reflux Disease,Gastro-Esophageal Reflux,Gastro-oesophageal Reflux,Gastroesophageal Reflux Disease,Reflux, Gastroesophageal,Acid Reflux, Gastric,Gastro Esophageal Reflux,Gastro Esophageal Reflux Disease,Gastro oesophageal Reflux,Gastro-Esophageal Reflux Diseases,Reflux Disease, Gastro-Esophageal,Reflux, Gastric Acid,Reflux, Gastro-Esophageal,Reflux, Gastro-oesophageal
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013657 Taurodeoxycholic Acid A bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. It is used as a cholagogue and choleretic, also industrially as a fat emulsifier. Deoxycholyltaurine,Taurine Deoxycholate,Taurodeoxycholate,Sodium Taurodeoxycholate,Acid, Taurodeoxycholic,Deoxycholate, Taurine,Taurodeoxycholate, Sodium

Related Publications

Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
March 1992, Journal of hepatology,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
January 1988, Medicina,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
August 1956, Missouri medicine,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
April 1987, Journal of hepatology,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
January 2017, Digestive surgery,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
April 1994, Gut,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
October 1995, Clinical nuclear medicine,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
January 1996, Ryoikibetsu shokogun shirizu,
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
January 1984, Hepatology (Baltimore, Md.),
Ulrich Baumgartner, and Jürgen Schölmerich, and Elisabeth Feuerstein, and Peter Baier, and Christian Ihling
August 1999, Digestive diseases and sciences,
Copied contents to your clipboard!